ExecPay

Mark W. Frohlich

Overview20152014

Overview

Mark W. Frohlich received an average of $2M in total compensation, including $383K in salary, at Juno Therapeutics between 2014 and 2015.

Source: SEC filing on April 20, 2016.
Frohlich's 2015 pay

Related executives

We found five more executives who work or worked at Juno Therapeutics.

Hans Bishop

Juno Therapeutics

Chief Executive Officer

4

Steven Harr

Juno Therapeutics

Chief Financial Officer

3

Hyam Levitsky

Juno Therapeutics

Chief Scientific Officer

2

Robert Azelby

Juno Therapeutics

Executive Vice President, Chief Commercial Officer

2

Bernard Cassidy

Juno Therapeutics

General Counsel

1

You may also like

Juno Therapeutics